CReSIL
CReSIL detects and characterizes extrachromosomal circular DNA (eccDNA) from long-read sequencing data to map eccDNA sequences, structures, and genomic origins.
Key Features:
- Long-Read Sequencing Integration: Leverages long-read sequencing technologies to construct comprehensive maps of eccDNA and resolve repetitive genomic regions relevant to eccDNA structure.
- High Performance: Demonstrates a minimum F1 score of 0.98 on simulated data for eccDNA identification.
- Genomic Annotation Capabilities: Provides genomic annotation to infer functional roles of identified eccDNAs, including associations with oncogenes.
- Visualization Tools: Produces Circos visualizations to investigate eccDNA architecture and genomic relationships.
Scientific Applications:
- Cancer Research: Maps eccDNAs that harbor oncogenes to study mechanisms of tumorigenesis and to investigate potential biomarkers or therapeutic targets.
- Dataset Validation: Validated across multiple long-read sequencing datasets, including eccDNA-enriched datasets and whole-genome datasets from cells containing large eccDNA products.
- EccDNA Structural Studies: Enables investigation of both complex and simple eccDNA structures in eukaryotic cells.
Methodology:
Implements a construction-based rolling-circle-amplification approach for eccDNA sequence identification and location, analyzes long-read sequencing data, performs genomic annotation, and generates Circos visualizations.
Topics
Details
- License:
- MIT
- Cost:
- Free of charge
- Tool Type:
- library
- Operating Systems:
- Mac, Linux, Windows
- Programming Languages:
- Python
- Added:
- 1/9/2023
- Last Updated:
- 11/24/2024
Operations
Publications
Wanchai V, Jenjaroenpun P, Leangapichart T, Arrey G, Burnham CM, Tümmler MC, Delgado-Calle J, Regenberg B, Nookaew I. CReSIL: accurate identification of extrachromosomal circular DNA from long-read sequences. Briefings in Bioinformatics. 2022;23(6). doi:10.1093/bib/bbac422. PMID:36198068. PMCID:PMC10144670.
DOI: 10.1093/bib/bbac422
PMID: 36198068
PMCID: PMC10144670
Funding: - Marie Skłodowska-Curie: 801199
- Innovation Fund Denmark under the Grand Solutions programme: 8088-00049B CARE DNA
- European Union’s Horizon 2020 research and innovation action under the FET-Open Programme: 899417—CIRCULAR VISION
- Villum Fonden: 00023247
- Novo Nordisk Foundation: NNF18OC0053139, NNF21OC0072023
- National Institutes of Health: P20GM125503, R37 CA251763, T32GM106999